2nd Quarter - Report

THE ROSS GROUP, LLC for AURINIA PHARMACEUTICALS

Firm
Client
Income
$22,500
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Lupus FDA approval of breakthrough therapies

Foreign entity interest: Aurinia Pharmaceuticals

LobbyistCovered position, as disclosed
SHALLA ROSS see prior filing

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.